Results 161 to 170 of about 2,285,924 (374)

Oral mucosal manifestations with identical mutations to the bone marrow in a patient with VEXAS syndrome

open access: yes
Rheumatology &Autoimmunity, EarlyView.
Lilian Vasaitis   +5 more
wiley   +1 more source

The wolf of hypomethylating agent failure: what comes next?

open access: yesHaematologica, 2019
Anne Sophie Kubasch, Uwe Platzbecker
doaj   +1 more source

Impact of methotrexate‐dosing regimens for GVHD prophylaxis on clinical outcomes of HLA‐matched allogeneic HSCT

open access: yesBritish Journal of Haematology, EarlyView.
Summary Severe graft‐versus‐host disease (GVHD) remains a major complication of allogeneic haematopoietic stem cell transplantation (allo‐HSCT), necessitating optimal immunosuppressive strategies. This retrospective study used data from the Japanese Transplant Registry Unified Management Program to compare three methotrexate (MTX)‐dosing regimens for ...
Tomotaka Suzuki   +17 more
wiley   +1 more source

Erythema Nodosum Associated with Myelodysplastic Syndrome: A Case Report [PDF]

open access: yes, 2011
Adam, Christian   +3 more
core   +1 more source

Patient Attitudes Toward Genetic Testing for Inherited Predispositions to Hematologic Malignancies [PDF]

open access: yes, 2018
Although inherited predispositions to hematologic malignancies have previously been considered extremely rare, approximately 12 causative genes have been implicated in the last decade.
Beecroft, Taylor
core   +1 more source

Globin chain synthesis in myelodysplastic syndromes. [PDF]

open access: bronze, 1991
G. Chalevelakis   +5 more
openalex   +1 more source

International scoring system for evaluating prognosis in myelodysplastic syndromes.

open access: yesBlood, 1997
P. Greenberg   +14 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy